Pre-diagnostic aspirin use and mortality after breast cancer.

Tengteng WangHumberto ParadaKathleen M McClainPatrick T BradshawMary Beth TerrySusan L TeitelbaumAlfred I NeugutMarilie D Gammon

Published in: Cancer causes & control : CCC (2018)

Pre-diagnosis aspirin use was not strongly associated with mortality following breast cancer. The all-cause mortality associations, however, were slightly stronger when we considered patterns of use.

Keyphrases

cardiovascular events
low dose
antiplatelet therapy
coronary artery disease
cardiovascular disease
risk factors
acute coronary syndrome
atrial fibrillation